Opportunity ID: 275551
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-PS15-1506 |
Funding Opportunity Title: | Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 24 |
Assistance Listings: | 93.940 — HIV Prevention Activities_Health Department Based |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 31, 2015 |
Last Updated Date: | Apr 14, 2015 |
Original Closing Date for Applications: | Jun 01, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | Jun 01, 2015 Applications must be submitted electronically no later than 11:59 p.m., ET, on June 1, 2015. |
Archive Date: | Jul 01, 2015 |
Estimated Total Program Funding: | $50,000,000 |
Award Ceiling: | $7,000,000 |
Award Floor: | $500,000 |
Eligibility
Eligible Applicants: | County governments State governments City or township governments |
Additional Information on Eligibility: | Eligibility for Category 1 (PrEP Support Demonstration Projects Targeting MSM and Transgender Persons at Substantial Risk of Acquiring HIV) is limited to health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year-end 2010 (2011 MSA report, table 6b, published Oct 2013). Eligibility for Category 2 (Data to Care Demonstration Projects That Use Surveillance Data Sources to Identify MSM and Transgender Persons Not in HIV Care) is limited to health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results. Complete laboratory reporting of CD4 and HIV viral load test results is defined as follows: The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department States that have local health departments directly funded by CDC are not eligible to apply for the MSAs/MDs that contain locally funded health departments within the state. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this FOA is to support up to 24 state and local health departments in the United States to implement PrEP (Category 1) and Data to Care (Category 2) demonstration projects prioritizing populations of MSM and transgender persons at high risk for HIV infection, particularly persons of color. Organizations that are funded under this FOA will be required to prioritize their services to these populations. Services may also be provided for persons at substantial risk for HIV (for PrEP) or persons who have HIV and are not virally suppressed or have ongoing risk behavior (for Data to Care) who are not MSM or transgender. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Carolyn Leighton
CYG8@cdc.gov Email:CYG8@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Applications must be submitted electronically no later than 11:59 p.m., ET, on June 1, 2015. | Apr 14, 2015 | |
Jun 18, 2016 | ||
Jun 18, 2016 | ||
Jun 18, 2016 | ||
Apr 14, 2015 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-PS15-1506 |
Funding Opportunity Title: | Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 24 |
Assistance Listings: | 93.940 — HIV Prevention Activities_Health Department Based |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Mar 31, 2015 |
Last Updated Date: | Apr 14, 2015 |
Original Closing Date for Applications: | Jun 01, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Current Closing Date for Applications: | Jun 01, 2015 Applications must be submitted electronically no later than 11:59 p.m., ET, on June 1, 2015. |
Archive Date: | Jul 01, 2015 |
Estimated Total Program Funding: | $50,000,000 |
Award Ceiling: | $7,000,000 |
Award Floor: | $500,000 |
Eligibility
Eligible Applicants: | County governments State governments City or township governments |
Additional Information on Eligibility: | Eligibility for Category 1 (PrEP Support Demonstration Projects Targeting MSM and Transgender Persons at Substantial Risk of Acquiring HIV) is limited to health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year-end 2010 (2011 MSA report, table 6b, published Oct 2013). Eligibility for Category 2 (Data to Care Demonstration Projects That Use Surveillance Data Sources to Identify MSM and Transgender Persons Not in HIV Care) is limited to health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results. Complete laboratory reporting of CD4 and HIV viral load test results is defined as follows: The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department States that have local health departments directly funded by CDC are not eligible to apply for the MSAs/MDs that contain locally funded health departments within the state. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this FOA is to support up to 24 state and local health departments in the United States to implement PrEP (Category 1) and Data to Care (Category 2) demonstration projects prioritizing populations of MSM and transgender persons at high risk for HIV infection, particularly persons of color. Organizations that are funded under this FOA will be required to prioritize their services to these populations. Services may also be provided for persons at substantial risk for HIV (for PrEP) or persons who have HIV and are not virally suppressed or have ongoing risk behavior (for Data to Care) who are not MSM or transgender. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Carolyn Leighton
CYG8@cdc.gov Email:CYG8@cdc.gov |
DISPLAYING: Forecast 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-PS15-1506 |
Funding Opportunity Title: | Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 24 |
Assistance Listings: | 93.940 — HIV Prevention Activities_Health Department Based |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 3 |
Posted Date: | Jun 18, 2016 |
Last Updated Date: | Jun 18, 2016 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Jun 26, 2015 |
Estimated Total Program Funding: | $210,000,000 |
Award Ceiling: | $7,000,000 |
Award Floor: | $500,000 |
Eligibility
Eligible Applicants: | State governments County governments City or township governments |
Additional Information on Eligibility: | Eligibility for Category 1 (PrEP Support Demonstration Projects Targeting MSM and Transgender Persons at Substantial Risk of Acquiring HIV) is limited to state and local health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year-end 2010 (2011 MSA report, table 6b, published Oct 2013). For the purposes of this FOA, definitions for the following terms apply: Metropolitan Statistical Area (MSA): MSA are geographic entities defined by the U.S. Office of Management and Budget (OMB) for use by Federal statistical agencies in collecting, tabulating and publishing Federal statistics. Furthermore, the underlying concept of a MSA is that of a core area containing a large population nucleus, together with adjacent communities having a high degree of economic and social integration with that core. MSA are composed of entire counties or county equivalents. Every MSA has at least one urbanized area with a population of 50,000 or more. Metropolitan Division: A metropolitan division (MD) is used to refer to a county or group of counties within a Metropolitan Statistical Area that has a population core of at least 2.5 million. (http://www.whitehouse.gov/omb/assets/bulletins/b10-02.pdf ) Eligibility for Category 2 (Data to Care Demonstration Projects That Use Surveillance Data Sources to Identify MSM and Transgender Persons Not in HIV Care) is limited to state and local health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results. Complete laboratory reporting of CD4 and HIV viral load test results is defined as follows: The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department A minimum of 95% of HIV-related test results from laboratories that perform HIV-related testing for each area are being reported to the state/city health department The jurisdiction is reporting at least 95% of all CD4 and viral load test results to CDC as of January 2014 (as outlined in the 2012 Monitoring Report, published in November 2014). |
Additional Information
Agency Name: | – |
Description: | The purpose of this FOA is to support up to 24 state and local health departments in the United States to implement PrEP (Category 1) and Data to Care (Category 2) demonstration projects prioritizing populations of MSM and transgender persons who have sex with men. Organizations that are funded under this FOA will be required to prioritize their services to these populations. Services may also be provided for persons at substantial risk for HIV (for PrEP) or persons who have HIV and are not virally suppressed or have ongoing risk behavior (for Data to Care) who are not MSM or transgender. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:CYG8@cdc.gov |
DISPLAYING: Forecast 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-PS15-1506 |
Funding Opportunity Title: | Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 24 |
Assistance Listings: | 93.940 — HIV Prevention Activities_Health Department Based |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 2 |
Posted Date: | Jun 18, 2016 |
Last Updated Date: | Jun 18, 2016 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Jun 26, 2015 |
Estimated Total Program Funding: | $210,000,000 |
Award Ceiling: | $7,000,000 |
Award Floor: | $500,000 |
Eligibility
Eligible Applicants: | State governments County governments City or township governments |
Additional Information on Eligibility: | Eligibility for Category 1 (PrEP Support Demonstration Projects Targeting MSM and Transgender Persons at Substantial Risk of Acquiring HIV) is limited to 24 state and local health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year-end 2010 (2011 MSA report, table 6b, published Oct 2013). For the purposes of this FOA, definitions for the following terms apply: Metropolitan Statistical Area (MSA): MSA are geographic entities defined by the U.S. Office of Management and Budget (OMB) for use by Federal statistical agencies in collecting, tabulating and publishing Federal statistics. Furthermore, the underlying concept of a MSA is that of a core area containing a large population nucleus, together with adjacent communities having a high degree of economic and social integration with that core. MSA are composed of entire counties or county equivalents. Every MSA has at least one urbanized area with a population of 50,000 or more. Metropolitan Division: A metropolitan division (MD) is used to refer to a county or group of counties within a Metropolitan Statistical Area that has a population core of at least 2.5 million. (http://www.whitehouse.gov/omb/assets/bulletins/b10-02.pdf ) Eligibility for Category 2 (Data to Care Demonstration Projects That Use Surveillance Data Sources to Identify MSM and Transgender Persons Not in HIV Care) is limited to 12 of the 24 state and local health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results. Complete laboratory reporting of CD4 and HIV viral load test results is defined as follows: The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department A minimum of 95% of HIV-related test results from laboratories that perform HIV-related testing for each area are being reported to the state/city health department The jurisdiction is reporting at least 95% of all CD4 and viral load test results to CDC as of January 2014 (as outlined in the 2012 Monitoring Report, published in November 2014). The eligible organizations are: Arizona Department of Health (Category 1) Baltimore Department of Health (Categories 1 and 2) California Department of Public Health (Office on AIDS) (Categories 1 and 2) Chicago Department of Public Health (Categories 1 and 2) City of Philadelphia Public Health Department (Category 1) Colorado Department of Health (Category 1) District of Columbia Department of Health (Categories 1 and 2) Florida State Department of Health (Category 1) Fulton County Department of Health and Wellness (Category 1) Houston Department of Health and Human Services (Categories 1 and 2) Los Angeles County Public Health Department (Categories 1 and 2) Louisiana Department of Health (Categories 1 and 2) Massachusetts Department of Public Health (Category 1) Michigan Department of Community Health (Categories 1 and 2) Minnesota Department of Health (Category 1) Missouri Department of Health and Senior Services (Categories 1 and 2) Nevada Department of Health (Category 1) New Jersey Department of Health and Senior Services (Category 1) New York City Department of Health and Mental Hygiene (Categories 1 and 2) San Francisco Department of Public Health (Categories 1 and 2) Tennessee Department of Health (Category 1) Texas State Department of Health Services (Categories 1 and 2) Virginia State Department of Health (Category 1) Washington State Department of Health (Category 1) |
Additional Information
Agency Name: | – |
Description: | State, local and territorial health departments in the US are implementing high impact HIV prevention programs to reduce new HIV infections among populations of gay, bisexual and other men who have sex with men (MSM) and transgender persons who have sex with men. Additional effort is needed to realize the benefits of new prevention strategies that have the potential to significantly reduce new HIV infections and increase viral suppression among MSM and transgender persons. Pre-exposure prophylaxis (PrEP) is a potent new prevention tool for MSM without HIV but who are at substantial risk of acquiring HIV infection. The daily use of oral, antiretroviral medication (PrEP) with co-formulated tenofovir disoproxil fumarate and emtricitabine (marketed as Truvada®) is proven to significantly reduce the risk of HIV acquisition among sexually active adults. In July 2012, the US Food and Drug Administration approved an HIV prevention indication for Truvada, and in May 2014 CDC published Public Health Service clinical practice guidelinesfor provision of PrEP to persons at substantial risk of HIV acquisition through sexual or injection routes of transmission as part of a package of HIV prevention clinical services. It is critical for state, local and territorial health departments to address barriers to and facilitate broader awareness, support and capacity for the scale-up of PrEP services for MSM, transgender persons, and other persons at substantial risk for HIV as part of a comprehensive HIV prevention portfolio. Another potent prevention tool involves antiretroviral medication to suppress HIV-1 viral load, improve health outcomes and reduce transmission risk among people living with HIV (PLWH). The importance of antiretroviral treatment has increased focus on interventions and public health strategies designed to link, engage and re-engage persons living with HIV in health care, with the ultimate outcome of suppressing HIV viral load, decreasing morbidity and increasing survival. In order to increase viral suppression, more people who are diagnosed with HIV will need to be retained in HIV medical care and receive antiretroviral treatment. There is a need for state, local and territorial health departments to implement public health strategies for improving linkage, engagement and re-engagement of MSM and transgender persons who are not in care. Data to Care is a public health strategy for identifying these individuals. Data to Care is based on the use of surveillance data to intervene directly in disease control. Data to Care programs use laboratory reports received by a health department’s HIV surveillance program, and a range of other data sources as markers of HIV care, and analyzes these reports to confidentially identify HIV-diagnosed individuals who are not engaged in HIV medical care or have not achieved viral suppression. Several state health departments have taken steps toward initiating a Data to Care program, and a few have reported successful implementation of Data to Care activities. It is important that these efforts be expanded and that other state, local and territorial health departments scale up and implement this promising public health strategy to improve outcomes along the HIV continuum of care and prevent new HIV infections. The purpose of this FOA is to support up to 24 state and local health departments in the United States to implement PrEP (Category 1) and Data to Care (Category 2) demonstration projects prioritizing populations of MSM and transgender persons who have sex with men. Organizations that are funded under this FOA will be required to prioritize their services to these populations. Services may also be provided for persons at substantial risk for HIV (for PrEP) or persons who have HIV and are not virally suppressed or have ongoing risk behavior (for Data to Care) who are not MSM or transgender. For Category 1, applicants should propose support activities to strengthen or enhance the ability to identify MSM and transgender persons who have sex with men who stand to benefit the most from PrEP, refer appropriate candidates to PrEP providers in the jurisdiction, and increase the number of providers knowledgeable and capable of offering PrEP to MSM and transgender persons who have sex with men. PrEP-related activities must be implemented as part of a comprehensive HIV prevention program that includes, when indicated, referral to prevention, screening and treatment services for STD, viral hepatitis, substance abuse, and mental health services. For Category 2, applicants should propose activities that support expanding or enhancing their ability to use HIV surveillance data and other data sources, as appropriate, to improve clinical outcomes along the HIV continuum of care for MSM and transgender persons. These activities use lab reports received by a health department’s surveillance system as markers for HIV care. Health departments should use these data to generate lists of individuals that may not have been linked to or who may have dropped out of HIV medical care. Several strategies, including conferences with health care providers and clinic staff, can occur to determine which names on the list are likely not in HIV care and should be prioritized for outreach. To improve outcomes along the continuum of HIV care for MSM and transgender persons who have sex with men, applicants should propose activities that use available data to improve identification, linkage to care, or re-engagement in care among persons not in care. These are key antecedents to improve HIV viral suppression among persons in care. Early activities for all proposed demonstration projects include: create new or expand existing partnerships with community-based organizations, LGBT organizations, private health care providers, clinics and community health centers; identify and convene Community Advisory Boards; develop provider buy-in and support; develop local evaluation framework for activities; assure compliance with CDC/NCHHSTP Security and Confidentiality Guidelines across all programs; and review of state and local laws and regulations affecting collection and use of HIV surveillance data (for Data to Care activities). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:CYG8@cdc.gov |
DISPLAYING: Forecast 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-PS15-1506 |
Funding Opportunity Title: | Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 24 |
Assistance Listings: | 93.940 — HIV Prevention Activities_Health Department Based |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Posted Date: | Jun 18, 2016 |
Last Updated Date: | Jun 18, 2016 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Jun 26, 2015 |
Estimated Total Program Funding: | $210,000,000 |
Award Ceiling: | $7,000,000 |
Award Floor: | $500,000 |
Eligibility
Eligible Applicants: | State governments County governments City or township governments |
Additional Information on Eligibility: | Eligibility for Category 1 is limited to 24 state and local health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year-end 2010 (2011 MSA report, table 6b, published Oct 2013). Eligibility for Category 2 is limited to 12 of the 24 state and local health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results. Complete laboratory reporting of CD4 and HIV viral load test results is defined as follows: The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department A minimum of 95% of HIV-related test results from laboratories that perform HIV-related testing for each area are being reported to the state/city health department The jurisdiction is reporting at least 95% of all CD4 and viral load test results to CDC as of January 2014 (as outlined in the 2012 Monitoring Report, published in November 2014). The eligible organizations are: Arizona Department of Health (Category 1) Baltimore Department of Health (Categories 1 and 2) California Department of Public Health (Office on AIDS) (Categories 1 and 2) Chicago Department of Public Health (Categories 1 and 2) City of Philadelphia Public Health Department (Category 1) Colorado Department of Health (Category 1) District of Columbia Department of Health (Categories 1 and 2) Florida State Department of Health (Category 1) Fulton County Department of Health and Wellness (Category 1) Houston Department of Health and Human Services (Categories 1 and 2) Los Angeles County Public Health Department (Categories 1 and 2) Louisiana Department of Health (Categories 1 and 2) Massachusetts Department of Public Health (Category 1) Michigan Department of Community Health (Categories 1 and 2) Minnesota Department of Health (Category 1) Missouri Department of Health and Senior Services (Categories 1 and 2) Nevada Department of Health (Category 1) New Jersey Department of Health and Senior Services (Category 1) New York City Department of Health and Mental Hygiene (Categories 1 and 2) San Francisco Department of Public Health (Categories 1 and 2) Tennessee Department of Health (Category 1) Texas State Department of Health Services (Categories 1 and 2) Virginia State Department of Health (Category 1) Washington State Department of Health (Category 1) |
Additional Information
Agency Name: | – |
Description: | State, local and territorial health departments in the US are implementing high impact HIV prevention programs to reduce new HIV infections among populations of gay, bisexual and other men who have sex with men (MSM) and transgender persons who have sex with men. Additional effort is needed to realize the benefits of new prevention strategies that have the potential to significantly reduce new HIV infections and increase viral suppression among MSM and transgender persons. Pre-exposure prophylaxis (PrEP) is a potent new prevention tool for MSM without HIV but who are at substantial risk of acquiring HIV infection. The daily use of oral, antiretroviral medication (PrEP) with co-formulated tenofovir disoproxil fumarate and emtricitabine (marketed as Truvada®) is proven to significantly reduce the risk of HIV acquisition among sexually active adults. In July 2012, the US Food and Drug Administration approved an HIV prevention indication for Truvada, and in May 2014 CDC published Public Health Service clinical practice guidelinesfor provision of PrEP to persons at substantial risk of HIV acquisition through sexual or injection routes of transmission as part of a package of HIV prevention clinical services. It is critical for state, local and territorial health departments to address barriers to and facilitate broader awareness, support and capacity for the scale-up of PrEP services for MSM, transgender persons, and other persons at substantial risk for HIV as part of a comprehensive HIV prevention portfolio. Another potent prevention tool involves antiretroviral medication to suppress HIV-1 viral load, improve health outcomes and reduce transmission risk among people living with HIV (PLWH). The importance of antiretroviral treatment has increased focus on interventions and public health strategies designed to link, engage and re-engage persons living with HIV in health care, with the ultimate outcome of suppressing HIV viral load, decreasing morbidity and increasing survival. In order to increase viral suppression, more people who are diagnosed with HIV will need to be retained in HIV medical care and receive antiretroviral treatment. There is a need for state, local and territorial health departments to implement public health strategies for improving linkage, engagement and re-engagement of MSM and transgender persons who are not in care. Data to Care is a public health strategy for identifying these individuals. Data to Care is based on the use of surveillance data to intervene directly in disease control. Data to Care programs use laboratory reports received by a health department’s HIV surveillance program, and a range of other data sources as markers of HIV care, and analyzes these reports to confidentially identify HIV-diagnosed individuals who are not engaged in HIV medical care or have not achieved viral suppression. Several state health departments have taken steps toward initiating a Data to Care program, and a few have reported successful implementation of Data to Care activities. It is important that these efforts be expanded and that other state, local and territorial health departments scale up and implement this promising public health strategy to improve outcomes along the HIV continuum of care and prevent new HIV infections. The purpose of this FOA is to support up to 24 state and local health departments in the United States to implement PrEP (Category 1) and Data to Care (Category 2) demonstration projects prioritizing populations of MSM and transgender persons who have sex with men. Organizations that are funded under this FOA will be required to prioritize their services to these populations. Services may also be provided for persons at substantial risk for HIV (for PrEP) or persons who have HIV and are not virally suppressed or have ongoing risk behavior (for Data to Care) who are not MSM or transgender. For Category 1, applicants should propose support activities to strengthen or enhance the ability to identify MSM and transgender persons who have sex with men who stand to benefit the most from PrEP, refer appropriate candidates to PrEP providers in the jurisdiction, and increase the number of providers knowledgeable and capable of offering PrEP to MSM and transgender persons who have sex with men. PrEP-related activities must be implemented as part of a comprehensive HIV prevention program that includes, when indicated, referral to prevention, screening and treatment services for STD, viral hepatitis, substance abuse, and mental health services. For Category 2, applicants should propose activities that support expanding or enhancing their ability to use HIV surveillance data and other data sources, as appropriate, to improve clinical outcomes along the HIV continuum of care for MSM and transgender persons. These activities use lab reports received by a health department’s surveillance system as markers for HIV care. Health departments should use these data to generate lists of individuals that may not have been linked to or who may have dropped out of HIV medical care. Several strategies, including conferences with health care providers and clinic staff, can occur to determine which names on the list are likely not in HIV care and should be prioritized for outreach. To improve outcomes along the continuum of HIV care for MSM and transgender persons who have sex with men, applicants should propose activities that use available data to improve identification, linkage to care, or re-engagement in care among persons not in care. These are key antecedents to improve HIV viral suppression among persons in care. Early activities for all proposed demonstration projects include: create new or expand existing partnerships with community-based organizations, LGBT organizations, private health care providers, clinics and community health centers; identify and convene Community Advisory Boards; develop provider buy-in and support; develop local evaluation framework for activities; assure compliance with CDC/NCHHSTP Security and Confidentiality Guidelines across all programs; and review of state and local laws and regulations affecting collection and use of HIV surveillance data (for Data to Care activities). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:CYG8@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | CDC-RFA-PS15-1506 |
Funding Opportunity Title: | Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 24 |
Assistance Listings: | 93.940 — HIV Prevention Activities_Health Department Based |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 14, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Jun 01, 2015 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
Archive Date: | Jul 01, 2015 |
Estimated Total Program Funding: | $50,000,000 |
Award Ceiling: | $7,000,000 |
Award Floor: | $500,000 |
Eligibility
Eligible Applicants: | State governments County governments City or township governments |
Additional Information on Eligibility: | Eligibility for Category 1 (PrEP Support Demonstration Projects Targeting MSM and Transgender Persons at Substantial Risk of Acquiring HIV) is limited to health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year-end 2010 (2011 MSA report, table 6b, published Oct 2013). For the purposes of this FOA, definitions for the following terms apply: Metropolitan Statistical Area (MSA): MSA are geographic entities defined by the U.S. Office of Management and Budget (OMB) for use by Federal statistical agencies in collecting, tabulating and publishing Federal statistics. Furthermore, the underlying concept of a MSA is that of a core area containing a large population nucleus, together with adjacent communities having a high degree of economic and social integration with that core. MSA are composed of entire counties or county equivalents. Every MSA has at least one urbanized area with a population of 50,000 or more. Metropolitan Division: A metropolitan division (MD) is used to refer to a county or group of counties within a Metropolitan Statistical Area that has a population core of at least 2.5 million. (http://www.whitehouse.gov/omb/assets/bulletins/b10-02.pdf ) Eligibility for Category 2 (Data to Care Demonstration Projects That Use Surveillance Data Sources to Identify MSM and Transgender Persons Not in HIV Care) is limited to health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results. The jurisdiction’s laws/regulations require the reporting of all CD4 and viral load results to the state/city health department |
Additional Information
Agency Name: | Centers for Disease Control and Prevention |
Description: | The purpose of this FOA is to support up to 24 state and local health departments in the United States to implement PrEP (Category 1) and Data to Care (Category 2) demonstration projects prioritizing populations of MSM and transgender persons who have sex with men. Organizations that are funded under this FOA will be required to prioritize their services to these populations. Services may also be provided for persons at substantial risk for HIV (for PrEP) or persons who have HIV and are not virally suppressed or have ongoing risk behavior (for Data to Care) who are not MSM or transgender. |
Link to Additional Information: | |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Carolyn Leighton
CYG8@cdc.gov Email:CYG8@cdc.gov |
Related Documents
Packages
Agency Contact Information: | Carolyn Leighton CYG8@cdc.gov Email: CYG8@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.940 | CDC-RFA-PS15-1506 | Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons | PKG00215900 | Mar 31, 2015 | Jun 01, 2015 | View |